Table 3.
Characteristics | Patients (n) | 2-year LC (%) | p value | 2-year PFS (%) | p value | 2-year OS (%) | p value | 2-year LPFS (%) | p value |
---|---|---|---|---|---|---|---|---|---|
Age (years) | |||||||||
> 75 | 45 | 97 | 0.822 | 83 | 0.793 | 85 | 0.454 | 86 | 0.663 |
≤ 75 | 51 | 96 | 84 | 94 | 90 | ||||
Sex | |||||||||
Male | 61 | 95 | 0.815 | 75 | 0.052 | 86 | 0.353 | 84 | 0.684 |
Female | 35 | 100 | 100 | 97 | 97 | ||||
T classification | |||||||||
T1a/T1b | 61 | 100 | 0.044 | 95 | < 0.001 | 98 | < 0.001 | 98 | < 0.001 |
T1c/T2a | 35 | 96 | 65 | 76 | 72 | ||||
History of lung surgery | |||||||||
Yes | 29 | 96 | 0.939 | 82 | 0.883 | 88 | 0.689 | 85 | 0.841 |
No | 67 | 97 | 85 | 91 | 90 | ||||
History of ischemic heart disease | |||||||||
Yes | 24 | 100 | 0.128 | 92 | 0.402 | 90 | 0.920 | 90 | 0.497 |
No | 72 | 95 | 82 | 90 | 87 | ||||
Histological diagnosis | |||||||||
Yes | 21 | 88 | 0.277 | 67 | 0.002 | 89 | 0.123 | 79 | 0.049 |
No | 75 | 90 | 88 | 98 | 91 | ||||
Operability | |||||||||
Operable | 25 | 100 | 0.226 | 85 | 0.786 | 96 | 0.747 | 96 | 0.411 |
Inoperable | 71 | 95 | 83 | 88 | 86 |
LC local control, PFS progression-free survival, OS overall survival, LPFS local progression-free survival